<DOC>
	<DOC>NCT00421135</DOC>
	<brief_summary>The study of safety of Isophosphoramide Mustard (IPM) in the treatment of advanced cancer.</brief_summary>
	<brief_title>A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<criteria>Metastatic and /or unresectable disease state after previous standard chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>